Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. 2007

Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
Seattle Biomedical Research Institute, Seattle, WA 98109, USA; Department of Pathobiology, University of Washington, Seattle, WA 98109, USA.

Eleven anti-HIV Env monoclonal antibodies (MAbs) were isolated from mice immunized with soluble Env proteins derived from the clade B Env, SF162, or DeltaV2 (a derivative of SF162 lacking the V2 loop). All six anti-gp120 MAbs studied, neutralized SF162 and their activities were dependent by the glycosylation patterns of the V1, V2 or V3 loops. Only one anti-gp120 MAb (an anti-V3 MAb) displayed cross-neutralizing activity, which was influenced by the type of V1 loop present on the target heterologous viruses. None of the five anti-gp41 MAbs studied displayed anti-SF162 neutralizing activity. Our studies indicate that the current limitation of soluble HIV Env gp140 immunogens to elicit robust cross-reactive neutralizing antibody responses is not only due to the elicitation of high titers of homologous antibodies but also due to the elicitation of antibodies whose epitopes are naturally occluded, or not present, on the virion-associated Env.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env

Related Publications

Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
March 2024, bioRxiv : the preprint server for biology,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
July 2011, Proceedings of the National Academy of Sciences of the United States of America,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
January 2013, PloS one,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
April 2020, Cell host & microbe,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
January 2007, Vaccine,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
June 2006, AIDS research and human retroviruses,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
January 2019, Frontiers in plant science,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
October 2014, Nature,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
January 2005, AIDS research and human retroviruses,
Nina R Derby, and Sean Gray, and Elizabeth Wayner, and Dwayne Campogan, and Giorgos Vlahogiannis, and Zane Kraft, and Susan W Barnett, and Indresh K Srivastava, and Leonidas Stamatatos
January 1991, Journal of molecular recognition : JMR,
Copied contents to your clipboard!